Sex, gender, and hemorrhagic fever viruses

Sex and Gender Differences in Infection and Treatments for Infectious Diseases

Volumn , Issue , 2015, Pages 211-230

  Klingström, Jonas ^a   Ahlm, Clas ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84955642757     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-16438-0_7     Document Type: Chapter

References (115)

1. Adam I, Karsany MS (2008) Case report: Rift Valley Fever with vertical transmission in a pregnant Sudanese woman. J Med Virol 80(5):929
2. Adam I, Jumaa AM, Elbashir HM, Karsany MS (2010) Maternal and perinatal outcomes of dengue in PortSudan, Eastern Sudan. Virol J 7:153
3. Agampodi SB, Wickramage K (2013) Is there a risk of yellow fever virus transmission in South Asian countries with hyperendemic dengue? Biomed Res Int 2013:905043
4. Ahlm C, Linderholm M, Juto P, Stegmayr B, Settergren B (1994) Prevalence of serum IgG antibodies to Puumala virus (hemorrhagic fever with renal syndrome) in Northern Sweden. Epidemiol Infect 113(1):129-136
5. Ajayi NA, Nwigwe CG, Azuogu BN, Onyire BN, Nwonwu EU, Ogbonnaya LU, Onwe FI, Ekaete T, Günther S, Ukwaja KN (2013) Containing a Lassa fever epidemic in a resourcelimited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012). Int J Infect Dis 17(11):e1011-e1016
6. Al-Hazmi M, Ayoola EA, Abdurahman M, Banzal S, Ashraf J, El-Bushra A, Hazmi A, Abdullah M, Abbo H, Elamin A, Al-Sammani e-T, Gadour M, Menon C, Hamza M, Rahim I, Hafez M, Jambavalikar M, Arishi H, Aqeel A (2003) Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis 36(3):245-252
7. Anders KL, Nguyet NM, Chau NV, Hung NT, Thuy TT, le Lien B, Farrar J, Wills B, Hien TT, Simmons CP (2011) Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg 84(1):127-134
8. Arishi HM, Aqeel AY, Al Hazmi MM (2006) Vertical transmission of fatal Rift Valley fever in a newborn. Ann Trop Paediatr 26(3):251-253
9. Bagamian KH, Towner JS, Mills JN, Kuenzi AJ (2013) Increased detection of Sin Nombre hantavirus RNA in antibody-positive deer mice from Montana, USA: evidence of male bias in RNA viremia. Viruses 5(9):2320-2328
10. Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot M-C, Deubel V (2004) Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J Immunol 172(5):2861-2869
11. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano ER, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Günther S (2014) Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371(15): 1418-1425
12. Bao CJ, Guo XL, Qi X, Hu JL, Zhou MH, Varma JK, Cui LB, Yang HT, Jiao YJ, Klena JD, Li LX, Tao WY, Li X, Chen Y, Zhu Z, Xu K, Shen AH, Wu T, Peng HY, Li ZF, Shan J, Shi ZY, Wang H (2011) A family cluster of infections by a newly recognized Bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis 53(12):1208-1214
13. Barrett AD, Monath TP, Barban V, Niedrig M, Teuwen DE (2007) 17D yellow fever vaccines: new insight. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005. Vaccine 25(15):2758-2765
14. Basurko C, Carles G, Youssef M, Guindi WE (2009) Maternal and fetal consequences of dengue fever during pregnancy. Eur J Obstet Gynecol Reprod Biol 147(1):29-32
15. Belet N, Top A, Terzi O, Arslan HN, Baysal K, Sensoy G (2014) Evaluation of children with Crimean-Congo hemorrhagic fever in the central Blacksea Region. Pediatr Infect Dis J 33(8): e194-197
16. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M (2013) Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 100(1):159-189
17. Biscayart C, Carrega ME, Sagradini S, Gentile A, Stecher D, Orduna T, Bentancourt S, Jiménez SG, Flynn LP, Arce GP, Uboldi MA, Bugna L, Morales MA, Digilio C, Fabbri C, Enría D, Diosque M, Vizzotti C (2014) Yellow fever vaccine-associated adverse events following extensive immunization in Argentina. Vaccine 32(11):1266-1272
18. Björkström NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, Michaëlsson J, Malmberg KJ, Klingström J, Ahlm C, Ljunggren HG (2011) Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 208(1):13-21
19. Bond N, Schieffelin JS, Moses LM, Bennett AJ, Bausch DG (2013) A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection. Am J Trop Med Hyg 88(2):241-244
20. Borucki MK, Boone JD, Rowe JE, Bohlman MC, Kuhn EA, DeBaca R, St Jeor SC (2000) Role of maternal antibody in natural infection of Peromyscus maniculatus with Sin Nombre virus. J Virol 74(5):2426-2429
21. Brundin P, Zhao C, Dahlman-Wright K, Ahlm C, Evengard B (2012) Gene expression of estrogen receptors in PBMC from patients with Puumala-virus infection. Shock 13(4):355-359
22. Celikbas AK, Dokuzöguz B, Baykam N, Gok SE, Eröglu MN, Midilli K, Zeller H, Ergonul O (2014) Crimean-Congo Hemorrhagic Fever among Health Care Workers, Turkey. Emerg Infect Dis 20(3):477-479
23. Clark DV, Jahrling PB, Lawler JV (2012) Clinical management of filovirus-infected patients. Viruses 4(9):1668-1686
24. Connolly-Andersen AM, Hammargren E, Whitaker H, Eliasson M, Holmgren L, Klingström J, Ahlm C (2014) Increased risk of acute myocardial infarction and stroke during hemorrhagic fever with renal syndrome: a self-controlled case series study. Circulation 129(12):1295-1302
25. Cui N, Bao XL, Yang ZD, Lu QB, Hu CY, Wang LY, Wang BJ, Wang HY, Liu K, Yuan C, Fan XJ, Wang Z, Zhang L, Zhang XA, Hu LP, Liu W, Cao WC (2014) Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China. J Clin Virol 59(1):12-17
26. Cummins D, McCormick JB, Bennett D, Samba JA, Farrar B, Machin SJ, Fisher-Hoch SP (1990) Acute sensorineural deafness in Lassa fever. JAMA 264(16):2093-2096
27. Deng B, Zhou B, Zhang S, Zhu Y, Han L, Geng Y, Jin Z, Liu H, Wang D, Zhao Y, Wen Y, Cui W, Zhou Y, Gu Q, Sun C, Lu X, Wang W, Wang Y, Li C, Wang Y, Yao W, Liu P (2013) Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PLoS ONE 8(11): e80802
28. Dixon MG, Schafer IJ (2014) Ebola viral disease outbreak - west Africa, 2014. MMWR Morb Mortal Wkly Rep 63(25):548-551
29. Dohmae K, Nishimune Y (1998) Maternal transfer of Hantavirus antibodies in rats. Lab Anim Sci 48(4):395-397
30. Duygu F, Kaya T, Baysan P (2012) Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable? Vector Borne Zoonotic Dis 12(9):812-816
31. Easterbrook JD, Klein SL (2008) Corticosteroids modulate Seoul virus infection, regulatory T-cell responses and matrix metalloprotease 9 expression in male, but not female, Norway rats. J Gen Virol 89(11):2723-2730
32. Ergonul O (2006) Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6(4):203-214
33. Ergonul O (2012) Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol 2(2):215-220
34. Falzarano D, Feldmann H (2013) Vaccines for viral hemorrhagic fevers-progress and shortcomings. Curr Opin Virol 3(3):343-351
35. Feldmann H, Geisbert TW (2011) Ebola haemorrhagic fever. Lancet 377(9768):849-862
36. Fichet-Calvet E, Rogers DJ (2009) Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis 3:e388
37. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, McCormick JB (1995) Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 311(7009):857-859
38. Flick R, Bouloy M (2005) Rift Valley fever virus. Curr Mol Med 5(8):827-834
39. Geisbert TW, Jahrling PB (2004) Exotic emerging viral diseases: progress and challenges. Nat Med 10(Suppl 12):S110-S121
40. Gire SK, Stremlau M, Andersen KG, Schaffner SF, Bjornson Z, Rubins K, Hensley L, McCormick JB, Lander ES, Garry RF, Happi C, Sabeti PC (2012) Epidemiology. Emerging disease or diagnosis? Science 338(6108):750-752
41. Guzmán MG, Kourí G (2002) Dengue: an update. Lancet Infect Dis 2(1):33-42
42. Hannah MF, Bajic VB, Klein SL (2008) Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats. Brain Behav Immunol 22(4):503-516
43. Hassan OA, Ahlm C, Sang R, Evander M (2011) The 2007 Rift Valley fever outbreak in Sudan. PLoS Negl Trop Dis 5(9):e1229
44. Hjertqvist M, Klein SL, Ahlm C, Klingstrom J (2010) Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis 16(10):1584-1586
45. Hofmann J, Führer A, Bolz M, Waldschläger-Terpe J, Meier M, Lüdders D, Enders M, Oltmann A, Meisel H, Krüger DH (2012) Hantavirus infections by Puumala or Dobrava-Belgrade virus in pregnant women. J Clin Virol 55(3):266-269
46. Hoogstraal H (1979) The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 15(4):307-417
47. Howard MJ, Doyle TJ, Koster FT, Zaki SR, Khan AS, Petersen EA, Peters CJ, Bryan RT (1999) Hantavirus pulmonary syndrome in pregnancy. Clin Infect Dis 29(6):1538-1544
48. Huggins JW (1989) Prospects for treatment of viral haemorrhagic fevers with ribavirin, a broadspectrum antiviral drug. Rev Infect Dis 11(Suppl 4):S750-S761
49. Huy NT, Van Giang T, Thuy DHD, Kikuchi M, Hien TT, Zamora J, Hirayama K (2013) Factors associated with dengue shock syndrome: a systematic review and meta-analysis. PLoS Negl Trop Dis 7(9):e2412
50. Jeffs B (2006) A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa. Trop Doct 36(1):1-4
51. Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ (1987) Clinical virology of Lassa fever in hospitalized patients. J Infect Dis 155(3):456-464
52. Johnson ED, Johnson BK, Silverstein D, Tukei P, Geisbert TW, Sanchez AN, Jahrling PB (1996) Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol 11:101-114
53. Jonsson CB, Figueiredo LTM, Vapalahti O (2010) A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease. Clin Microbiol Rev 23(2):412-441
54. Kallio ER, Poikonen A, Vaheri A, Vapalahti O, Henttonen H, Koskela E, Mappes T (2006) Maternal antibodies postpone hantavirus infection and enhance individual breeding success. Proc Biol Sci 273(1602):2771-2776
55. Kallio ER, Henttonen H, Koskela E, Lundkvist A, Mappes T, Vapalahti O (2013) Maternal antibodies contribute to sex-based difference in hantavirus transmission dynamics. Biol Lett 9(6):20130887
56. Keshtkar-Jahromi M, Kuhn JH, Christova I, Bradfute SB, Jahrling PB, Bavari S (2011) Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antiviral Res 90(2):85-92
57. Klein SL (2012) Sex differences in prophylaxis and therapeutic treatments for viral diseases. Handb Exp Pharmacol 214:499-522
58. Klein SL, Jedlicka A, Pekosz A (2010) The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 10(5):338-349
59. Klein SL, Marks MA, Li W, Glass GE, Fang LQ, Ma JQ, Cao WC (2011) Sex differences in the incidence and case fatality rates from hemorrhagic fever with renal syndrome in China, 2004-2008. Clin Infect Dis 13(12):1414-1421
60. Klingström J, Lindgren T, Ahlm C (2008) Sex-dependent differences in plasma cytokine responses to hantavirus infection. Clin Vaccine Immunol 13(5):885-887
61. Kortepeter MG, Bausch DG, Bray M (2011) Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 204(Suppl 3):S810-S816
62. Krautkrämer E, Grouls S, Urban E, Schnitzler P, Zeier M (2013) No gender-related differences in the severity of nephropathia epidemica, Germany. BMC Infect Dis 13:457
63. LaBeaud AD, Muchiri EM, Ndzovu M, Mwanje MT, Muiruri S, Peters CJ, King CH (2008) Interepidemic Rift Valley fever virus seropositivity, Northeastern Kenya. Emerg Inf Dis 14(8):1240-1246
64. Leroy EM, Gonzalez JP, Baize S (2011) Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect 17(7):964-976
65. Lindgren T, Ahlm C, Mohamed N, Evander M, Ljunggren HG, Björkström NK (2011) Longitudinal analysis of the human T cell response during acute hantavirus infection. J Virol 85(19):10252-10260
66. Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB (2008) Adverse event reports following yellow fever vaccination. Vaccine 26(48):6077-6082
67. Liu W, Lu QB, Cui N, Li H, Wang LY, Liu K, Yang ZD, Wang BJ, Wang HY, Zhang YY, Zhuang L, Hu CY, Yuan C, Fan XJ, Wang Z, Zhang L, Zhang XA, Walker DH, Cao WC (2013) Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis 57(9):1292-1299
68. Machado CR, Machado ES, Rohloff RD, Azevedo M, Campos DP, de Oliveira RB, Brasil P (2013) Is pregnancy associated with severe dengue? A review of data from the Rio de Janeiro surveillance information system. PLoS Negl Trop Dis 7(5):e2217
69. MacNeil A, Rollin PE (2012) Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Negl Trop Dis 6(6):e1546
70. Makary P, Kanerva M, Ollgren J, Virtanen MJ, Vapalahti O, Lyytikäinen O (2010) Disease burden of Puumala virus infections, 1995-2008. Epidemiol Infect 138(10):1484-1492
71. Makela S, Jaatinen P, Miettinen M, Salmi J, Ala-Houhala I, Huhtala H, Hurme M, Pörsti I, Vaheri A, Mustonen J (2010) Hormonal deficiencies during and after Puumala hantavirus infection. Eur J Clin Microbiol Infect Dis 29(6):705-713
72. Martinez VP, Bellomo CM, Cacace ML, Suarez P, Bogni L, Padula PJ (2010) Hantavirus pulmonary syndrome in Argentina, 1995-2008. Emerg Infect Dis 16(12):1853-1860
73. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES (1987) A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 155(3):437-444
74. McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, Spiropoulou CF (2014) Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis 210(4):558-566
75. McLay L, Liang Y, Ly H (2014) Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. J Gen Virol 95(1):1-15
76. Mertens M, Wölfel R, Ullrich K, Yoshimatsu K, Blumhardt J, Römer I, Esser J, Schmidt-Chanasit J, Groschup MH, Dobler G, Essbauer SS, Ulrich RG (2009) Seroepidemiological study in a Puumala virus outbreak area in South-East Germany. Med Microbiol Immunol 198(2):83-91
77. Mofleh J, Ahmad Z (2012) Crimean-Congo haemorrhagic fever outbreak investigation in the Western Region of Afghanistan in 2008. East Mediterr Health J 18(5):522-526
78. Mohamed M, Mosha F, Mghamba J, Zaki SR, Shieh WJ, Paweska J, Omulo S, Gikundi S, Mmbuji P, Bloland P, Zeidner N, Kalinga R, Breiman RF, Njenga MK (2010) Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hyg 83(Suppl 2):22-27
79. Monath TP (2012) Review of the risks and benefits of yellow fever vaccination including some new analyses. Expert Rev Vaccines 11(4):427-448
80. Monath TP, Craven RB, Adjukiewicz A, Germain M, Francy DB, Ferrara L, Samba EM, N'Jie H, Cham K, Fitzgerald SA, Crippen PH, Simpson DI, Bowen ET, Fabiyi A, Salaun JJ (1980) Yellow fever in the Gambia, 1978-1979: epidemiologic aspects with observations on the occurrence of orungo virus infections. Am J Trop Med Hyg 29(5):912-928
81. Mousavi-Jazi M, Karlberg H, Papa A, Christova I, Mirazimi A (2012) Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine. Vaccine 30(44):6225-6229
82. Naderi HR, Sarvghad MR, Bojdy A, Hadizadeh MR, Sadeghi R, Sheybani F (2011) Nosocomial outbreak of Crimean-Congo haemorrhagic fever. Epidemiol Infect 139(6):862-866
83. Nguku PM, Sharif SK, Mutonga D, Amwayi S, Omolo J, Mohammed O, Farnon EC, Gould LH, Lederman E, Rao C, Sang R, Schnabel D, Feikin DR, Hightower A, Njenga MK, Breiman RF (2010) An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007. Am J Trop Med Hyg 83(Suppl 2):5-13
84. Niklasson B, Liljestrand J, Bergström S, Peters CJ (1987) Rift Valley fever: a seroepidemiological survey among pregnant women in Mozambique. Epidemiol Infect 99(2):517-522
85. Nordin JD, Parker ED, Vazquez-Benitez G, Kharbanda EO, Naleway A, Marcy SM, Molitor B, Kuckler L, Baggs J (2013) Safety of the yellow Fever vaccine: a retrospective study. J Travel Med 20(6):368-373
86. Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD (2013) Bradycardia seen in children with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis 13(11):807-811
87. Oldstone MBA, Campbell KP (2011) Decoding arenavirus pathogenesis: essential roles for alphadystroglycan-virus interactions and the immune response. Virology 411(2):170-179
88. Papa A, Papadimitriou E, Christova I (2011) The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain. Scand J Infect Dis 43(3):225-229
89. Papa A, Sidira P, Larichev V, Gavrilova L, Kuzmina K, Mousavi-Jazi M, Mirazimi A, Ströher U, Nichol S (2014) Crimean-congo hemorrhagic Fever virus, Greece. Emerg Infect Dis 20(2):288-290
90. Pettersson L, Boman J, Juto P, Evander M, Ahlm C (2008) Outbreak of Puumala virus infection, Sweden. Emerg Infect Dis 14(5):808-810
91. Pettersson L, Thunberg T, Rocklöv J, Klingström J, Evander M, Ahlm C (2014) Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients-implications for treatment. Clin Microbiol Infect 20(3):235-241
92. Pouliot SH, Xiong X, Harville E, Paz-Soldan V, Tomashek KM, Breart G, Buekens P (2010) Maternal dengue and pregnancy outcomes: a systematic review. Obstet Gynecol Surv 65(2):107-118
93. Rasmuson J, Lindqvist P, Sörensen K, Hedström M, Blomberg A, Ahlm C (2013) Cardiopulmonary involvement in Puumala hantavirus infection. BMC Infect Dis 13:501
94. Sargianou M, Papa A (2013) Epidemiological and behavioral factors associated with Crimean-Congo hemorrhagic fever virus infections in humans. Expert Rev Anti Infect Ther 11(9):897-908
95. Schmaljohn C (2009) Vaccines for hantaviruses. Vaccine 27(Suppl 4):D61-D64
96. Seligman SJ (2011) Yellow fever virus vaccine-associated deaths in young women. Emerg Infect Dis 17(10):1891-1893
97. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M (2008) Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J 27(6):561-563
98. Sisman A (2013) Epidemiologic features and risk factors of Crimean-Congo hemorrhagic fever in Samsun province, Turkey. J Epidemiol 23(2):95-102
99. Stojanovic M, Pekic S, Cvijovic G, Miljic D, Doknic M, Nikolic-Djurovic M, Micic D, Hrvacevic R, Nesic V, Popovic V (2008) High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome. J Clin Endocrinol Metab 93(7):2722-2728
100. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S (1989) The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 11(Suppl 4):S794-S800
101. Tan PC, Soe MZ, Si Lay K, Wang SM, Sekaran SD, Omar SZ (2012) Dengue infection and miscarriage: a prospective case control study. PLoS Negl Trop Dis 6(5):e1637
102. Teixeira MG, Siqueira JB Jr, Ferreira GL, Bricks L, Joint G (2013) Epidemiological trends of dengue disease in Brazil (2000-2010): a systematic literature search and analysis. PLoS Negl Trop Dis 7(12):e2520
103. Tezer H, Sucakli IA, Sayli TR, Celikel E, Yakut I, Kara A, Tunc B, Ergonul O (2010) Crimean-Congo hemorrhagic fever in children. J Clin Virol 48(3):184-186
104. Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB (1988) Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg 38(2):407-410
105. Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, Kemp A, Swanepoel R, Paddock CD, Balinandi S, Khristova ML, Formenty PB, Albarino CG, Miller DM, Reed ZD, Kayiwa JT, Mills JN, Cannon DL, Greer PW, Byaruhanga E, Farnon EC, Atimnedi P, Okware S, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Ksiazek TG, Nichol ST, Rollin PE (2009) Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 5(7):e1000536
106. Tuboi SH, Costa ZG, da Costa Vasconcelos PF, Hatch D (2007) Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002. Trans R Soc Trop Med Hyg 101(2):169-175
107. Tuygun N, Tanir G, Caglayik DY, Uyar Y, Korukluoglu G, Cenesiz F (2012) Pediatric cases of Crimean-Congo hemorrhagic fever in Turkey. Pediatr Int 54(3):402-406
108. Wen HL, Zhao L, Zhai S, Chi Y, Cui F, Wang D, Wang L, Wang Z, Wang Q, Zhang S, Liu Y, Yu H, Yu XJ (2014) Severe fever with thrombocytopenia syndrome, Shandong Province, China, 2011. Emerg Infect Dis 20(1):1-5
109. Whitehorn J, Simmons CP (2011) The pathogenesis of dengue. Vaccine 29(42):7221-7228
110. WHO (2007) Addressing sex and gender in epidemic-prone infectious diseases. WHO, Geneva. http://www.who.int/csr/resources/publications/SexGenderInfectDis.pdf. Accessed 24 Feb 2014
111. Yagci-Caglayik D, Korukluoglu G, Uyar Y (2014) Seroprevalence and risk factors of Crimean-Congo hemorrhagic fever in selected seven provinces in Turkey. J Med Virol 86(2):306-314
112. Yilmaz GR, Buzgan T, Torunoglu MA, Safran A, Irmak H, Com S, Uyar Y, Carhan A, Ozkaya E, Ertek M (2008) A preliminary report on Crimean-Congo haemorrhagic fever in Turkey. Euro Surveill 13(33):18953
113. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, Torunoglu MA (2009) The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis 13(3):380-386
114. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, Qu J, Li Q, Zhang YP, Hai R, Wu W, Wang Q, Zhan FX, Wang XJ, Kan B, Wang SW, Wan KL, Jing HQ, Lu JX, Yin WW, Zhou H, Guan XH, Liu JF, Bi ZQ, Liu GH, Ren J, Wang H, Zhao Z, Song JD, He JR, Wan T, Zhang JS, Fu XP, Sun LN, Dong XP, Feng ZJ, Yang WZ, Hong T, Zhang Y, Walker DH, Wang Y, Li DX (2011) Fever with thrombocytopenia associated with a novel Bunyavirus in China. N Engl J Med 364(16):1523-1532
115. Zhang YZ, Zou Y, Fu ZF, Plyusnin A (2010) Hantavirus infections in humans and animals, China. Emerg Infect Dis 16(8):1195-1203